# Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.

> **NCT01890408** · PHASE2 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 5 (actual)

## Conditions studied

- Laparotomy
- Hepatic Resection

## Interventions

- **DRUG:** wound infusion ropivacaine

## Key facts

- **NCT ID:** NCT01890408
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** promoter decision
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890408, "Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01890408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*